Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,268

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,852

Class I recallsReasonable probability of serious health consequences

24,397

Class II recallsTemporary or medically reversible health consequences

2,897

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,085 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/family-farmstead-dairy-announces-recall-raw-mild-cheddar-cheese-due-potential-e-coli-o157h7Published October 15, 2026

Most affected stateHawaii 200 recalls mention this state

State: MD ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 16, 2026 ET

Summary (Year to date)

1,739 recalls have been announced year to date.
Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (300).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,397
Class I	9,852
Class III	2,897
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,397
Class I	9,852
Class III	2,897
Not Yet Classified	2

FDA Recall United States TerminatedTerminated: April 7, 20262026 recordClass II

Wawa Beverage Company

Product: Wawa Chocolate Low-fat Milk 16 oz , (Pint) Plastic bottle .S…
Reason: Foreign plastic material discovered on fill line.
Published: March 25, 2026
Distribution: The recalled product was distributed to…

View recall →

FDA Recall United States TerminatedTerminated: April 7, 20262026 recordClass II

Wawa Beverage Company

Product: Wawa Cookies & Cream Milk 16 oz (Pint), Plastic bottle Store…
Reason: Foreign plastic material discovered on fill line.
Published: March 25, 2026
Distribution: The recalled product was distributed to…

View recall →

FDA Recall United States TerminatedTerminated: April 7, 20262026 recordClass II

Wawa Beverage Company

Product: Wawa Double Dutch Chocolate Milk ,16 oz (Pint) Plastic bottl…
Reason: Foreign plastic material discovered on fill line.
Published: March 25, 2026
Distribution: The recalled product was distributed to…

View recall →

FDA Recall United States TerminatedTerminated: April 7, 20262026 recordClass II

Wawa Beverage Company

Product: Wawa Reduced Fat Milk 2% 16 oz (Pint)
Reason: Foreign plastic material discovered on fill line.
Published: March 25, 2026
Distribution: The recalled product was distributed to…

View recall →

FDA Recall United States TerminatedTerminated: June 17, 20262026 recordClass I

Bluegrass Ingredients Inc.

Product: Butter Powder, Net Weight 50 LB., packaged in a multiply Kra…
Reason: Positive Salmonella contamination
Published: March 25, 2026
Distribution: Multiple states

View recall →

FDA Recall United States TerminatedTerminated: June 17, 20262026 recordClass I

Bluegrass Ingredients Inc.

Product: Butter-Rich Powder, Net Weight 50 LB., packaged in a multipl…
Reason: Potential Salmonella contamination
Published: March 25, 2026
Distribution: Multiple states

View recall →

FDA Recall United States TerminatedTerminated: September 3, 20262026 recordClass II

Dr. Praeger's Sensible Foods Inc.

Product: Simply Nature, Spinach Bites, 12 oz retail unit, Plastic wra…
Reason: This product has the possibility of contamination with rodent hair.
Published: March 25, 2026
Distribution: The adulterated product was distributed…

View recall →

FDA Recall Ongoing2026 recordClass II

Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1592-7

by Zydus Pharmaceuticals (USA) Inc

Reason: Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.
Published: March 18, 2026
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: August 13, 20262026 recordClass I

Ambrosia Brands LLC

Product: Rosabella brand MORINGA; DIETARY SUPPLEMENT CAPSULES; 60 cap…
Reason: Product may be contaminated with Salmonella
Published: March 18, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Amnesteem (Isotretinoin) Capsules, USP 40 mg, packaged in 3 x 10-Count Prescription Packs, Rx Only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV, 26505 USA, Made in France, NDC 0378-6614-93.

by MYLAN PHARMACEUTICALS INC

Reason: Failed Dissolution Specifications
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass I

Mojo Max Fusion XXX, 500 mg, one capsule per blister card, 20 count box, Distributed by: Max Nutrition Inc. UPC 6 78945 36675 0

by Mohamed Hagar

Reason: Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; Order 49317, 49323, 49325, 49329, 49333, 49339, 49341,49355, 49364, 49380, 49392. (b) 2 ml V-Vial, NDC 69208-003-25; Order 49353,49457, 49477. (c) 3 ml V-vial, NDC 69208-003-35; Order 49454,49406. Rx Only, Manufactured by: International Isotopes Inc., Idaho Falls, ID.

by Radnostix

Reason: Presence of Particulate Matter: Due to production issues
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass I

SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China

by ANTHONY TRINH, 123Herbals LLC

Reason: Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

MAXIMUM, ZONE 2, 4% Lidocaine Cream, (Lidocaine 4% and Epinephrine 0.01%), 1 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-015.

by HTO Nevada Inc. dba Kirkman

Reason: Stability Data Does Not Support Expiry Date.
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

MAXIMUM, ZONE 1, 4% Lidocaine Cream, 1/2 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-014.

by HTO Nevada Inc. dba Kirkman

Reason: Stability Data Does Not Support Expiry Date.
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

FIVE-STAR, VASOCAINE Spray, (Lidocaine HCl 4%, Racepinephrine HCl 0.01%), 4oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-016.

by HTO Nevada Inc. dba Kirkman

Reason: Stability Data Does Not Support Expiry Date.
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Country of origin: Taiwan, NDC 16571-816-51.

by Rising Pharma Holding, Inc.

Reason: Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06.

by The Harvard Drug Group LLC

Reason: Defective container; inadequately sealed blister packaging.
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass III

Nilotinib Capsules, 200 mg per capsule, packaged in cartons, Rx only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, Outer carton: 112 capsules (4 individual packs containing 28 capsules each), NDC 69097-032-74; Inner carton: 28 capsules (4 blisters of 7 capsules), NDC 69097-032-56; Foil blister: NDC 69097-032-17

by Cipla USA, Inc.

Reason: Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass III

Nilotinib Capsules, 150 mg per capsule, packaged in cartons, Rx only, Manufactured by: Cipla Ltd., Verna, Goa, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, Outer carton: 112 capsules (4 individual packs containing 28 capsules each) NDC 69097-031-74; Inner carton: 28 capsules (4 blisters of 7 capsules) NDC 69097-031-56; Foil blister: NDC 69097-031-17

by Cipla USA, Inc.

Reason: Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.
Published: March 11, 2026
Distribution: Nationwide

View recall →

Data last updated: October 16, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.